Further, the slow metabolism within the NP in combination with a half-life of 12±2.0 years for aggrecan [26], [46] may also have led to the accumulation of CML within healthy NPs. This evidence concerns the gene ACAN and chronic myelogenous leukemia, BCR-ABL1 positive.